These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18309713)

  • 1. Increased level of urinary nitric oxide metabolites in leprosy patients during type 2 reactions and decreased after antireactional therapy.
    Mohanty KK; Gupta M; Girdhar BK; Girdhar A; Chakma JK; Sengupta U
    Lepr Rev; 2007 Dec; 78(4):386-90. PubMed ID: 18309713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum zinc/copper ratio in subtypes of leprosy and effect of oral zinc therapy on reactional states.
    George J; Bhatia VN; Balakrishnan S; Ramu G
    Int J Lepr Other Mycobact Dis; 1991 Mar; 59(1):20-4. PubMed ID: 2030313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose prednisolone treatment of leprosy patients undergoing reactions is associated with a rapid decrease in urinary nitric oxide metabolites and clinical improvement.
    Schön T; Leekassa R; Gebre N; Sundqvist T; Bizuneh E; Britton S
    Lepr Rev; 2000 Sep; 71(3):355-62. PubMed ID: 11105495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increase in nitric oxide concentrations in serum and mononuclear cell cultures from patients with Type II reaction state of Hansen's disease].
    Rada E; Marzal M; Aranzazu N; Convit J
    Invest Clin; 2003 Jun; 44(2):129-36. PubMed ID: 12815843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased chitotriosidase activity in serum of leprosy patients: association with bacillary leprosy.
    Iyer A; van Eijk M; Silva E; Hatta M; Faber W; Aerts JM; Das PK
    Clin Immunol; 2009 Jun; 131(3):501-9. PubMed ID: 19307157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor response in lepromatous leprosy patients: role of Leu 2a cells.
    del Carmen Sasiain M; de la Barrera S; Ruibal-Ares B; Cardama JE; Gatti JC; de Bracco MM
    Immunology; 1987 Jan; 60(1):13-8. PubMed ID: 2950048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
    Rea TH; Sieling PA
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum.
    Sasiain MC; Ruibal Ares B; Baliña LM; Valdez R; Bachmann AE
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):321-7. PubMed ID: 6227570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the treatment of reactions in leprosy.
    Girdhar BK; Girdhar A; Chakma JK
    Indian J Lepr; 2007; 79(2-3):121-34. PubMed ID: 18085170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
    Gupta N; Shankernarayan NP; Dharmalingam K
    J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some unusual type 2 reactions in leprosy.
    Ramesh V; Pahwa M
    Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
    Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
    Front Immunol; 2018; 9():189. PubMed ID: 29479352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.